Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients

By Kruijf Esther  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 687-696

Springer Publishing Company

Access to resources Recommend Favorite

The prognostic value of apoptotic and proliferative markers in breast cancer

By Engels Charla   Ruberta Francesca   Kruijf Esther   Pelt Gabi   Smit Vincent   Liefers Gerrit   Matsushima Tomoko   Shibayama Masaki   Ishihara Hideki   Velde Cornelis   Kuppen Peter  

Breast Cancer Research and Treatment, Vol. 142, Iss. 2, 2013-11 ,pp. : 323-339

Springer Publishing Company

Access to resources Recommend Favorite

Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients

By Gilje Bjørnar   Nordgård Oddmund   Tjensvoll Kjersti   Janssen Emiel   Søiland Håvard   Smaaland Rune   Baak Jan  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 137-146

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer

By Tsutsui S.  

Breast Cancer Research and Treatment, Vol. 71, Iss. 1, 2002-01 ,pp. : 67-75

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

By Powell B.L.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 65-68

Springer Publishing Company

Access to resources Recommend Favorite